✦ LIBER ✦

Systemic pentoxifylline decreases mortality in severe burn patients with inhalation injury: Preliminary report of a randomized controlled trial

✍ Scribed by C. Pedreros; L. Parada; J.C. Said; C. Longton

Book ID: 116329730
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 66 KB
Volume: 33
Category: Article
ISSN: 0305-4179
DOI: 10.1016/j.burns.2006.10.140

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival of severe ARDS with five-organ

Survival of severe ARDS with five-organ system failure following burns and inhalation injury in a 15-year-old patient

✍ Can Cedidi; Robert Hierner; Maximilian Pichlmaier; Wolf-Georg Forssmann; Markus 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Pilot multicenter, genotype-based, rando

Pilot multicenter, genotype-based, randomized, double-blind, placebo-controlled trial of propranolol to reduce initial pain symptoms in patients with major burn injury

✍ D. Orrey; J. Shupp; J. Hoskins; T. Platts-Mills; A. Bortsov; S. Bangdiwala; L. H 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 35 KB

PRS3 Inhaled Anticholinergics and Risk o

PRS3 Inhaled Anticholinergics and Risk of All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta Analysis of Randomized Controlled Trials

✍ M.R. Ajmera; P.B. Rane; G. Kelley; U. Sambamoorthi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

The effect of moderate-dose corticostero

The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: Findings of a prospective, randomized, double-blind, placebo-controlled trial

✍ Chung-E Tseng; Jill P. Buyon; Mimi Kim; H. Michael Belmont; Meggan Mackay; Betty 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## Objective Serial measurements of anti–double‐stranded DNA (anti‐dsDNA) and complement are routine in the management of systemic lupus erythematosus (SLE), but their utility as biomarkers in preemptive treatment to prevent flares remains a subject of controversy. We hypothesized that

Impact of adalimumab treatment on health

Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis

✍ D. Revicki; M.K. Willian; J.-H. Saurat; K.A. Papp; J.-P. Ortonne; C. Sexton; A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB